Last reviewed · How we verify

NCT03638024

Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .

Status unknown Last updated 9 October 2018
What this trial tests

trial testing Maternal plasma cell free fetal DNA levels in Placenta Accreta in 50 participants. Status unknown.

Timeline
1 September 2018
Primary endpoint
3 March 2019
3 April 2019

Quick facts

Lead sponsorAin Shams Maternity Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 September 2018
Primary completion3 March 2019
Estimated completion3 April 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams Maternity Hospital

Who can join

Adults 20 to 40, female only, with Placenta Accreta or Placenta Percreta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cell free fetal DNA might predict abnormal placental invasion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Placenta Accreta

Currently open trials in the same condition.

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03638024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing